Loading…
Orchard Therapeutics is a biotechnology company focused on developing hematopoietic stem cell (HSC) gene therapies for severe genetic diseases. The company aims to change treatment paradigms for patients with conditions like metachromatic leukodystrophy (MLD).
AI named Orchard Therapeutics in November 2025.